Form 8-K EAGLE FINANCIAL SERVICES For: May 19
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
An Annual Meeting of Shareholders of Eagle Financial Services, Inc. (the “Company”) was held on May 19, 2026, for the purpose of considering and acting upon the following matters:
The final voting results for each proposal, including the votes for and against, and any withheld, abstained, or broker non-votes, are described below.
Proposal 1 – Election of Directors
The Company’s shareholders elected all six nominees for director. For each nominee, the votes cast for and against, as well as withheld and broker non-votes, were as follows:
|
For |
|
Withheld |
|
Broker Non-Votes |
Brandon C. Lorey |
3,545,730 |
|
62,736 |
|
514,936 |
Douglas C. Rinker |
3,413,048 |
|
195,418 |
|
514,936 |
John D. Stokely |
3,413,365 |
|
195,101 |
|
514,936 |
Brian T. Strosser |
3,473,284 |
|
135,182 |
|
514,936 |
Susan D. Davies |
3,473,595 |
|
134,871 |
|
514,936 |
Karthik Shyamsunder |
3,545,975 |
|
62,491 |
|
514,936 |
|
|
|
|
|
|
Proposal 2 – Approval of Eagle Financial Services, Inc. 2026 Employee Stock Purchase Plan
The Company’s shareholders approved the 2026 Employee Stock Purchase Plan. The votes cast for and against this proposal, as well as votes abstained and, broker non-votes, were as follows:
For |
|
Against |
|
Abstain |
|
Broker Non-Votes |
3,321,310 |
|
195,071 |
|
92,083 |
|
514,937 |
Proposal 3 – Ratification of Appointment of Independent Registered Public Accounting Firm
The Company’s shareholders approved the ratification of the Audit Committee’s selection of Yount, Hyde & Barbour, P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The votes cast for and against this proposal, as well as the votes abstained, were as follows:
For |
|
Against |
|
Abstain |
4,080,508 |
|
24,801 |
|
18,092 |
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit |
|
Description |
No. |
|
|
|
|
|
104 |
|
Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Eagle Financial Services, Inc. |
|
|
|
|
Date: |
May 20, 2026 |
By: |
/s/ KATHLEEN J. CHAPPELL |
|
|
|
Kathleen J. Chappell |
ATTACHMENTS / EXHIBITS
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Windstar Opens Asia 2028/2029 Season as Demand Surges, Bringing Small-Ship Access to the Heart of Bangkok and Ho Chi Minh City
- Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain
- BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Advances ONC010 Program With Successful 300-Gram API Scale-Up Batch
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share